A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The study is being performed to assess the safety, tolerability, and pharmacokinetic (PK) and
pharmacodynamic (PD) properties of single oral doses of DBPR108 in healthy male subjects.